2-methyl-6-nitrobenzoic anhydride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methyl-6-nitrobenzoic anhydride: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	10472648
SCHEMBL ID	329162
MeSH ID	M0518957

Synonyms (29)

Synonym
AKOS015842197
2-methyl-6-nitrobenzoic anhydride, 97%
mnba
FT-0658534
6-nitro-o-toluic anhydride
434935-69-0
2-methyl-6-nitrobenzoic anhydride
M1439
A826295
2-methyl-6-nitrobenzoic acid [(2-methyl-6-nitrophenyl)-oxomethyl] ester
(2-methyl-6-nitro-phenyl)carbonyl 2-methyl-6-nitro-benzoate
c16h12n2o7
SCHEMBL329162
AM83027
2-methyl-6-nitrobenzoic acid anhydride
YEKPNMQQSPHKBP-UHFFFAOYSA-N
2-methyl-6-nitrobenzoicanhydride
benzoic acid, 2-methyl-6-nitro-, anhydride
DTXSID60440549
mfcd06797117
CS-W008194
2-methyl-6-nitrobenzoyl 2-methyl-6-nitrobenzoate
(2-methyl-6-nitrobenzoyl) 2-methyl-6-nitrobenzoate
DS-18220
Q11186403
p-nitrobenzyl2-diazoacetoacetate
SY075637
unii-ec8mk6fe8b
ec8mk6fe8b ,

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	6 (75.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	24.11 (24.57)
Research Supply Index	2.20 (2.92)
Research Growth Index	4.66 (4.65)
Search Engine Demand Index	23.28 (26.88)
Search Engine Supply Index	2.00 (0.95)

This Compound (24.11)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (12.50%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	7 (87.50%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
beta-alanine [no description available]	3.21	1	amino acid zwitterion; beta-amino acid	agonist; fundamental metabolite; human metabolite; inhibitor; neurotransmitter
1-anilino-8-naphthalenesulfonate 1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd. 8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.	2.07	1	aminonaphthalene; naphthalenesulfonic acid	fluorescent probe
erythromycin Erythromycin: A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin : Any of several wide-spectrum macrolide antibiotics obtained from actinomycete Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus).. erythromycin A : An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.	2.05	1	cyclic ketone; erythromycin
osmium Osmium: A very hard, gray, toxic, and nearly infusible metal element, atomic number 76, atomic weight 190.2, symbol Os.	3.21	1	iron group element atom; platinum group metal atom
n-methylisatoic anhydride N-methylisatoic anhydride: structure given in first source; used to prepare N-methylanthranilyl (Mantyl) peptide derivatives. N-methylisatoic anhydride : A 3,1-benzoxazin-1,4-dione having an N-methyl substituent.	2.07	1	benzoxazine
dolastatin 16 dolastatin 16: from sea hare Dolabella auricularia; structure given in first source	2.11	1
erythronolide a erythronolide A: structure in first source	2.05	1	erythronolide
lipstatin lipstatin: isolated from Streptomyces toxytricini; inhibitor of pancreatic lipase; structure given in first source	2.07	1
cyanolide a cyanolide A: molluscicidal from the Papua New Guinea cyanobacterium Lyngbya bouillonii; structure in first source	2.05	1
destruxin e destruxin E: cyclodepsipeptide from entomopathogenic fungus Metarhyzium anisopliae; structure given in first source	3.61	2	cyclodepsipeptide

chemdatabank.com